Turbidity changes and plasma concentrations of total CRP, total VLDL, and calculated levels of CRP in complex with VLDL from 15 patients with positive BPW
| Patient . | Total CRP (mg/L) . | VLDL cholesterol (mM) . | Calculated CRP in complex (mg/L) . | Turbidity Δτ405 . |
|---|---|---|---|---|
| 1 | 266 | 1.327 | 254 | 0.290 |
| 2 | 398 | 0.292 | 97 | 0.145 |
| 3 | 219 | 0.316 | 100 | 0.062 |
| 4 | 342 | 0.248 | 80 | 0.048 |
| 5 | 294 | 0.498 | 159 | 0.033 |
| 6 | 323 | 0.204 | 67 | 0.095 |
| 7 | 355 | 0.810 | 254 | 0.288 |
| 8 | 314 | 0.389 | 127 | 0.162 |
| 9 | 361 | 0.627 | 203 | 0.401 |
| 10 | 220 | 0.260 | 84 | 0.057 |
| 11 | 387 | 0.414 | 137 | 0.187 |
| 12 | 274 | 0.339 | 110 | 0.143 |
| 13 | 212 | 0.423 | 130 | 0.146 |
| 14 | 274 | 0.333 | 108 | 0.106 |
| 15 | 77 | 0.082 | 24 | 0.021 |
| NHP | 1.3 | 0.389 | 1.2 | 0 |
| Patient . | Total CRP (mg/L) . | VLDL cholesterol (mM) . | Calculated CRP in complex (mg/L) . | Turbidity Δτ405 . |
|---|---|---|---|---|
| 1 | 266 | 1.327 | 254 | 0.290 |
| 2 | 398 | 0.292 | 97 | 0.145 |
| 3 | 219 | 0.316 | 100 | 0.062 |
| 4 | 342 | 0.248 | 80 | 0.048 |
| 5 | 294 | 0.498 | 159 | 0.033 |
| 6 | 323 | 0.204 | 67 | 0.095 |
| 7 | 355 | 0.810 | 254 | 0.288 |
| 8 | 314 | 0.389 | 127 | 0.162 |
| 9 | 361 | 0.627 | 203 | 0.401 |
| 10 | 220 | 0.260 | 84 | 0.057 |
| 11 | 387 | 0.414 | 137 | 0.187 |
| 12 | 274 | 0.339 | 110 | 0.143 |
| 13 | 212 | 0.423 | 130 | 0.146 |
| 14 | 274 | 0.333 | 108 | 0.106 |
| 15 | 77 | 0.082 | 24 | 0.021 |
| NHP | 1.3 | 0.389 | 1.2 | 0 |
VLDL is the average value, normalized to cholesterol, based on measured levels of cholesterol, ApoB-100, and total protein in the VLDL fraction. CRP in complex was calculated using equation 2 in “Patients, materials, and methods” and parameters for the interaction between CRP and VLDL in lipoprotein-deficient plasma (Kd = 9.63 CRP [mg/L]; n = 343 CRP [mg/L]/mM VLDL cholesterol). NHP indicates normal human plasma.